Clinical trial
A Multi-institutional, Randomized Controlled, Phase II Clinical Trial on Comparison of Efficacy and Safety of Nedaplatin Plus 5-Fu Combined With and Without Endostar® Continuous Intravenous Infusion in Refractory Nasopharyngeal Carcinoma
NCT02590133 is registered in ClinicalTrials.gov with Yun-fei Xia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-institutional, Randomized Controlled, Phase II Clinical Trial on Comparison of Efficacy and Safety of Nedaplatin Plus 5-Fu Combined With and Without Endostar® Continuous Intravenous Infusion in Refractory Nasopharyngeal Carcinoma
- Lead sponsor
- Yun-fei Xia
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 31, 2015
- Completion date
- December 31, 2020
- Enrollment
- 328 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.